FDA hits CDMO Ei for making drugs and pesticides with same equipment

The FDA hit Ei, a CDMO, with a warning letter for manufacturing pharmaceuticals in the same building and with the same equipment it uses to produce pesticides.In its letter posted to the regulatory agency’s website, the FDA outlined poor manufacturing procedures at the company’s facility located in Kannapolis, North Carolina. The plant, which produces finished pharmaceuticals like liquid and semisolid topical drugs, was inspected in early October 2017.The agency said inspectors found the company “manufactured topical human drugs and several pesticides in the same building, using shared equipment” despite the risk of cross contamination. Inspectors also found two of the drugs meant for human use contained a pesticide produced at the facility.